Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


29.05.2017

8 Am Heart J
18 Am J Cardiol
3 Ann Thorac Surg
1 Cardiovasc Res
2 Chest
1 Circulation
1 Eur Heart J
6 Eur J Heart Fail
2 Int J Cardiol
3 J Am Coll Cardiol
3 J Card Fail
1 J Cardiol
1 N Engl J Med
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. PROIETTI M, Laroche C, Drozd M, Vijgen J, et al
    Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Am Heart J. 2016;181:83-91.
    PubMed     Text format     Abstract available

  2. BAKKESTROM R, Larsen LA, Moller JE, Videbaek L, et al
    Mitral valve regurgitation in twins: Concordance and survival.
    Am Heart J. 2016;177:51-7.
    PubMed     Text format     Abstract available

  3. KIM EJ, Yin X, Fontes JD, Magnani JW, et al
    Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study).
    Am Heart J. 2016;177:138-44.
    PubMed     Text format     Abstract available

  4. PEGUERO JG, Lo Presti S, Issa O, Podesta C, et al
    Simplified prediction of postoperative cardiac surgery outcomes with a novel score: R2CHADS2.
    Am Heart J. 2016;177:153-9.
    PubMed     Text format     Abstract available

  5. SHAH R, Hellkamp A, Lokhnygina Y, Becker RC, et al
    Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial.
    Am Heart J. 2016;179:77-86.
    PubMed     Text format     Abstract available

  6. MARSO SP, McGuire DK, Zinman B, Poulter NR, et al
    Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1.
    Am Heart J. 2016;179:175-83.
    PubMed     Text format     Abstract available

  7. BUCK J, Kaboli P, Gage BF, Cram P, et al
    Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System.
    Am Heart J. 2016;179:186-91.
    PubMed     Text format     Abstract available

  8. MCNEELY C, Markwell S, Vassileva CM
    Readmission after inpatient percutaneous coronary intervention in the Medicare population from 2000 to 2012.
    Am Heart J. 2016;179:195-203.
    PubMed     Text format     Abstract available


    Am J Cardiol

  9. SHERAZI S, Kutyifa V, McNitt S, Papernov A, et al
    Effect of Gender on the Risk of Neurologic Events and Subsequent Outcomes in Patients With Left Ventricular Assist Devices.
    Am J Cardiol. 2017;119:297-301.
    PubMed     Text format     Abstract available

  10. PATEL NJ, Pau D, Nalluri N, Bhatt P, et al
    Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention.
    Am J Cardiol. 2016 Jul 29. pii: S0002-9149(16)31234.
    PubMed     Text format     Abstract available

  11. TISMINETZKY M, Chen HY, McManus DD, Gurwitz J, et al
    Trends in the Magnitude of, and Patient Characteristics Associated With, Multiple Hospital Readmissions After Acute Myocardial Infarction.
    Am J Cardiol. 2016 Jul 29. pii: S0002-9149(16)31237.
    PubMed     Text format     Abstract available

  12. CASTILLO-MORENO JA, Garcia-Escribano IA, Martinez-Pascual-de-Riquelme M, Jaulent-Huertas L, et al
    Prognostic Usefulness of the 6-Minute Walk Test in Patients With Severe Aortic Stenosis.
    Am J Cardiol. 2016 Jul 29. pii: S0002-9149(16)31251.
    PubMed     Text format     Abstract available

  13. PROVIDENCIA R, Boveda S, Defaye P, Segal O, et al
    Outcome of Primary Prevention Implantable Cardioverter Defibrillator Therapy According to New York Heart Association Functional Classification.
    Am J Cardiol. 2016 Jul 29. pii: S0002-9149(16)31246.
    PubMed     Text format     Abstract available

  14. SUKSARANJIT P, McGann CJ, Akoum N, Biskupiak J, et al
    Prognostic Implications of Left Ventricular Scar Determined by Late Gadolinium Enhanced Cardiac Magnetic Resonance in Patients With Atrial Fibrillation.
    Am J Cardiol. 2016 Jul 18. pii: S0002-9149(16)31179.
    PubMed     Text format     Abstract available

  15. WANG YC, Tang A, Chang D, Lu CQ, et al
    Long-Term Adverse Effects of Low-Osmolar Compared With Iso-Osmolar Contrast Media After Coronary Angiography.
    Am J Cardiol. 2016 Jul 18. pii: S0002-9149(16)31188.
    PubMed     Text format     Abstract available

  16. LYNGBAKKEN MN, Rosjo H, Holmen OL, Nygard S, et al
    Gender, High-Sensitivity Troponin I, and the Risk of Cardiovascular Events (from the Nord-Trondelag Health Study).
    Am J Cardiol. 2016 Jun 28. pii: S0002-9149(16)31114.
    PubMed     Text format     Abstract available

  17. LEE MJ, Jang JH, Lee MD, Kwon SW, et al
    Prognostic Implications of Newly Developed T-Wave Inversion After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
    Am J Cardiol. 2016 Nov 16. pii: S0002-9149(16)31807.
    PubMed     Text format     Abstract available

  18. NESTOROVIC EM, Grupper A, Joyce LD, Milic NM, et al
    Effect of Pretransplant Continuous-Flow Left Ventricular Assist Devices on Cellular and Antibody-Mediated Rejection and Subsequent Allograft Outcomes.
    Am J Cardiol. 2017;119:452-456.
    PubMed     Text format     Abstract available

  19. MARTENS P, Verbrugge FH, Nijst P, Dupont M, et al
    Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30709.
    PubMed     Text format     Abstract available

  20. MUKHERJEE M, Sharma K, Madrazo JA, Tedford RJ, et al
    Right-Sided Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction and Worsening Renal Function.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30707.
    PubMed     Text format     Abstract available

  21. CHEN DC, Singh GD, Armstrong EJ, Waldo SW, et al
    Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30044.
    PubMed     Text format     Abstract available

  22. ABE M, Ogawa H, Ishii M, Masunaga N, et al
    Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (from the Fushimi AF Registry).
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30054.
    PubMed     Text format     Abstract available

  23. HARADA K, Suzuki S, Ishii H, Aoki T, et al
    Impact of Skeletal Muscle Mass on Long-Term Adverse Cardiovascular Outcomes in Patients With Chronic Kidney Disease.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30042.
    PubMed     Text format     Abstract available

  24. JAAKKOLA S, Lip GY, Biancari F, Nuotio I, et al
    Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score).
    Am J Cardiol. 2016 Dec 2. pii: S0002-9149(16)31895.
    PubMed     Text format     Abstract available

  25. BOBBO M, Pinamonti B, Merlo M, Stolfo D, et al
    Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
    Am J Cardiol. 2016 Nov 11. pii: S0002-9149(16)31725.
    PubMed     Text format     Abstract available

  26. RAMKUMAR S, Yang H, Wang Y, Nolan M, et al
    Relation of Functional Status to Risk of Development of Atrial Fibrillation.
    Am J Cardiol. 2016 Nov 16. pii: S0002-9149(16)31815.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  27. BARTOLI CR, Kang J, Zhang D, Howard J, et al
    Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System.
    Ann Thorac Surg. 2017;103:1239-1244.
    PubMed     Text format     Abstract available

  28. SOOD V, Alam O, Tchantchaleishvili V, Pagani FD, et al
    Correlation of Pre-Explant Lactate Dehydrogenase Concentrations and Findings During Post-Explant Pump Analysis of the HeartMate II Left Ventricular Assist Device.
    Ann Thorac Surg. 2017;103:1207-1213.
    PubMed     Text format     Abstract available

  29. NETUKA I, Litzler PY, Berchtold-Herz M, Flecher E, et al
    Outcomes in HeartMate II Patients With No Antiplatelet Therapy: 2-Year Results From the European TRACE Study.
    Ann Thorac Surg. 2017;103:1262-1268.
    PubMed     Text format     Abstract available


    Cardiovasc Res

  30. ABDURRACHIM D, Nabben M, Hoerr V, Kuhlmann MT, et al
    Diabetic db/db mice do not develop heart failure upon pressure overload: A longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations.
    Cardiovasc Res. 2017 May 26. doi: 10.1093.
    PubMed     Text format     Abstract available


    Chest

  31. ROZENBAUM Z, Khoury S, Aviram G, Gura Y, et al
    Discriminating Circulatory Problems From Deconditioning: Echocardiographic and Cardiopulmonary Exercise Test Analysis.
    Chest. 2017;151:431-440.
    PubMed     Text format     Abstract available

  32. SCHWANN TA, Habib RH, Suri RM, Brennan JM, et al
    Variation in Warfarin Use at Hospital Discharge After Isolated Bioprosthetic Mitral Valve Replacement - An Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database.
    Chest. 2016 Apr 28. pii: S0012-3692(16)48651-4. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


    Circulation

  33. PARIKH KS, Lippmann SJ, Greiner M, Heidenreich PA, et al
    Scope of Sacubitril/Valsartan Eligibility After Heart Failure Hospitalization: Findings From the GWTG-HF Registry (Get With The Guidelines-Heart Failure).
    Circulation. 2017;135:2077-2080.
    PubMed     Text format    


    Eur Heart J

  34. SCUFFHAM PA, Ball J, Horowitz JD, Wong C, et al
    Standard vs. intensified management of heart failure to reduce healthcare costs: results of a multicentre, randomized controlled trial.
    Eur Heart J. 2017 May 20. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur J Heart Fail

  35. POPESCU BA, Beladan CC, Popescu AC
    Mechanical dyssynchrony in heart failure with preserved ejection fraction: a treatment target or a dead end?
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    

  36. METRA M, Ravera A, Filippatos G
    Understanding worsening heart failure as a therapeutic target: another step forward?
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    

  37. PASCUAL-FIGAL DA
    Acute heart failure and biomarkers: time also matters, don't relax.
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    

  38. VADUGANATHAN M, Patel RB, Butler J, Metra M, et al
    Integrating electronic health records into the study of heart failure: promises and pitfalls.
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    

  39. CHIRINOS JA, Londono-Hoyos F, Zamani P, Beraun M, et al
    Effects of organic and inorganic nitrate on aortic and carotid haemodynamics in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format     Abstract available

  40. VEGTER EL, van der Meer P, Voors AA
    Associations between volume status and circulating microRNAs in acute heart failure.
    Eur J Heart Fail. 2017 May 25. doi: 10.1002.
    PubMed     Text format    


    Int J Cardiol

  41. CASADO J, Sanchez M, Garces V, Manzano L, et al
    Influence of renal dysfunction phenotype on mortality in decompensated heart failure with preserved and mid-range ejection fraction.
    Int J Cardiol. 2017 May 12. pii: S0167-5273(16)32858.
    PubMed     Text format     Abstract available

  42. NIJST P, Verbrugge FH, Martens P, Dupont M, et al
    Renal response to intravascular volume expansion in euvolemic heart failure patients with reduced ejection fraction: Mechanistic insights and clinical implications.
    Int J Cardiol. 2017 May 14. pii: S0167-5273(17)31183.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  43. BILCHICK KC, Wang Y, Cheng A, Curtis JP, et al
    Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
    J Am Coll Cardiol. 2017;69:2606-2618.
    PubMed     Text format     Abstract available

  44. CARR H, Cnattingius S, Granath F, Ludvigsson JF, et al
    Preterm Birth and Risk of Heart Failure Up to Early Adulthood.
    J Am Coll Cardiol. 2017;69:2634-2642.
    PubMed     Text format     Abstract available

  45. LEESON P, Lewandowski AJ
    A New Risk Factor for Early Heart Failure: Preterm Birth.
    J Am Coll Cardiol. 2017;69:2643-2645.
    PubMed     Text format    


    J Card Fail

  46. PLEHN JF
    The Conundrum of Patient Selection in Trials of Heart Failure with Preserved Ejection Fraction: Exploring the Benefits and Risks of Focused Phenotyping.
    J Card Fail. 2017 May 22. pii: S1071-9164(17)30151.
    PubMed     Text format    

  47. KALOGEROPOULOS AP
    Risk Prediction Models for Incident Heart Failure: Beyond Statistical Validity.
    J Card Fail. 2017 May 18. pii: S1071-9164(17)30146.
    PubMed     Text format    

  48. PAGE RL 2ND, Lindenfeld J
    Ground Hog Day: Do We Need Another Analysis of Diuretic Dose and Outcomes in Heart Failure Patients?
    J Card Fail. 2017 May 18. pii: S1071-9164(17)30148.
    PubMed     Text format    


    J Cardiol

  49. YANG LT, Kado Y, Nagata Y, Otani K, et al
    Timing on echocardiography and blood laboratory test is important for future outcome association in hospitalized heart failure patients.
    J Cardiol. 2017 May 22. pii: S0914-5087(17)30114.
    PubMed     Text format     Abstract available


    N Engl J Med

  50. DE DENUS S, O'Meara E, Desai AS, Claggett B, et al
    Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation.
    N Engl J Med. 2017;376:1690-1692.
    PubMed     Text format    


    PLoS One

  51. STRAM AR, Wagner GR, Fogler BD, Pride PM, et al
    Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy.
    PLoS One. 2017;12:e0178354.
    PubMed     Text format     Abstract available

  52. ALBADRI A, Lai K, Wei J, Landes S, et al
    Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    PLoS One. 2017;12:e0177684.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: